CoChat

In-depth analysis of lupeol: delving into the diverse pharmacological profile

Open access

The DOI matches its Crossref record; 266 of the 276 references it cites were found in a registry or an index.

Abstract

Lupeol, a naturally occurring lupane-type pentacyclic triterpenoid, is widely distributed in various edible vegetables, fruits, and medicinal plants. Notably, it is found in high concentrations in plants like Tamarindus indica , Allanblackia monticola , and Emblica officinalis , among others. Quantitative studies have highlighted its presence in Elm bark, Olive fruit, Aloe leaf, Ginseng oil, Mango pulp, and Japanese Pear bark. This compound is synthesized from squalene through the mevalonate pathway and can also be synthetically produced in the lab, addressing challenges in natural product synthesis. Over the past four decades, extensive research has demonstrated lupeol’s multifaceted pharmacological properties, including anti-inflammatory, antioxidant, anticancer, and antibacterial effects. Despite its significant therapeutic potential, clinical applications of lupeol have been limited by its poor water solubility and bioavailability. Recent advancements have focused on nano-based delivery systems to enhance its bioavailability, and the development of various lupeol derivatives has further amplified its bioactivity. This review provides a comprehensive overview of the latest advancements in understanding the pharmacological benefits of lupeol. It also discusses innovative strategies to improve its bioavailability, thereby enhancing its clinical efficacy. The aim is to consolidate current knowledge and stimulate further research into the therapeutic potential of lupeol and its derivatives.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2024.1461478

Cites

266 of 266 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Chemical structure of lupeol.
FIGURE 1 Chemical structure of lupeol.CC BY · PubMed Central
FIGURE 2 Biosynthesis of lupeol via mevalonic acid (MVA) pathway.
FIGURE 2 Biosynthesis of lupeol via mevalonic acid (MVA) pathway.CC BY · PubMed Central
FIGURE 3 Mechanism of lupeol on the apoptotic pathway.
FIGURE 3 Mechanism of lupeol on the apoptotic pathway.CC BY · PubMed Central
FIGURE 4 Mechanism of Lupeol’s cardioprotective and anti-atherosclerotic activities.
FIGURE 4 Mechanism of Lupeol’s cardioprotective and anti-atherosclerotic activities.CC BY · PubMed Central
FIGURE 5 Mechanism of Lupeol’s Dermatoprotective actions.
FIGURE 5 Mechanism of Lupeol’s Dermatoprotective actions.CC BY · PubMed Central
FIGURE 6 Impact of lupeol on various types of disorders.
FIGURE 6 Impact of lupeol on various types of disorders.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Items 201–266 of 266

Research works printed but not linked: 16

  1. Deshmukh A. S. Morankar P. G. Kumbhare M. R. (2014). Review on analgesic activity and determination methods. PhTechMed 3 (1).
  2. Devi S. K. Vishnpriya V. Ponnulakshmi R. Gayahtri R. Shymaladevi B. Madhan K. (2019). Lupeol regulates glucose transporter-4 and AS160 in adipose tissue of high-fat diet-fed diabetic rats. Drug Invent. Today 12 (6), 1118– 1190.
  3. Gayathri G. R. Krishnan M. Jayaraman S. Dhivyadharshini A. Vishnpriya V. Ponnulakshmi R. (2019a). Effect of lupeol on insulin receptor substrate-1 and AKt expression in adipose tissue of type-2 diabetic rats. Drug Invent. Today 12. Available at: https://www.researchgate.net/publication/370770179.
  4. Gayathri G. R. Krishnan M. Jayaraman S. Jayavabhushana V. Vishnupriya V. Ponnulakshmi R. (2019b). Lupeol supplementation attenuates overexpression of sterol regulatory element-binding protein in hepatocytes: an experimental study. Drug Invent. Today 12. Available at: https://www.researchgate.net/publication/370770232.
  5. Gayathri G. R. Krishnan M. Shreenithi S. Vishnupriya V. Ponnulakshmi R. Gayathri R. (2019c). In silico and in vivo approach to identify the antidiabetic activity of lupeol. Drug Invent. Today 11. Available at: https://www.researchgate.net/publication/370560564.
  6. Jayaraman S. Krishnan M. Deepika R. Selvaraj J. Vishnupriya V. Ponnulakshmi R. (2019). Effects of lupeol on insulin receptor substrate-2 and its phosphorylation in the liver of high-fat diet and sucrose-induced type-2 diabetic rats. Drug Invent. Today 12. Available at: https://www.researchgate.net/publication/370769794.
  7. Kaviya N. E. Vishnupriya V. Ponnulakshmi R. Gayathri G. R. Krishnan M. Jayaraman S. (2019). Lupeol protects kidney from high-fat diet-induced renal damage: an experimental study. Drug Invent. Today 12. Available at: https://www.researchgate.net/publication/370770959.
  8. Khan M. F. Maurya C. K. Dev K. Arha D. Rai A. K. Tamrakar A. K. (2014b). Design and synthesis of lupeol analogues and their glucose uptake stimulatory effect in L6 skeletal muscle cells. Bioorg. Med. Chem. Lett. 24 (12), 2674– 2679. 10.1016/j.bmcl.2014.04.059 24813738 · DOI
  9. Lee H.-A. Han J.-S. (2022). Facilitation of glucose uptake by lupeol through the activation of the PI3K/AKT and AMPK dependent pathways in 3T3-L1 adipocytes. J. Life Sci. 32 (2), 86– 93. 10.5352/JLS.2022.32.2.86 · doi:10.5352/jls.2022.32.2.86
  10. Minda D. Pavel I. Z. Borcan F. Coricovac D. Pinzaru I. Andrica F. (2015). Beneficial effects of a lupeol-cyclodextrin complex in a murine model of photochemical skin carcinoma. Rev. Chim. 66, 373– 377.
  11. Padmapriya N. Selvaraj J. Vishnupriya V. Ponnulakshmi R. Gayathri B. Shyamaladevi B. (2019). Effects of lupeol on insulin receptor and glucose transporter-4 in cardiac tissue of Type-2 diabetic rats. In Drug Invent. Today 12.
  12. Pereira Beserra F. Sérgio Gushiken L. F. Vieira A. J. Augusto Bérgamo D. Luísa Bérgamo P. Oliveira de Souza M. (2020). From inflammation to cutaneous repair: topical application of lupeol improves skin wound healing in rats by modulating the cytokine levels, NF-κB, ki-67, growth factor expression, and distribution of collagen fibers. Int. J. Mol. Sci. 21 (14), 4952. 10.3390/ijms21144952 32668794 PMC7404060 · DOI
  13. Pereira Beserra F. Xue M. Maia G. L. A. Leite Rozza A. Helena Pellizzon C. Jackson C. J. (2018). Lupeol, a pentacyclic triterpene, promotes migration, wound closure, and contractile effect in vitro: possible involvement of pi3k/akt and p38/erk/mapk pathways. Molecules 23 (11), 2819– 1021. 10.3390/molecules23112819 30380745 PMC6278408 · DOI
  14. Roitt I. Brostoff J. Male D. (2001). Immunology. 6th ed. London: Mosby.
  15. Tchimene M. K. Nwaehujor C. O. Ezenwali M. Okoli C. C. M Iwu M. (2016b). Free radical scavenging activity of lupeol isolated from the methanol leaf extract of Crateva adansonii oliv (capparidaceae). Int. J. Pharmacogn. Phytochemical Res. 8 (3), 419– 426.
  16. Tiwari A. Gandhi S. Joshi M. (2019). Effect of lupeol in diabetic nephropathy and its anti-oxidant mechanism. Int. J. Adv. Sci. Technol. 28 (20), 1404– 1413.

Cited by

See all 50

Metadata

Authors
Dalimunthe, A., Carensia Gunawan, M., Dhiya Utari, Z., Dinata, M. R., Halim, P., Estherina S. Pakpahan, N., Sitohang, A. I., Sukarno, M. A., Yuandani, Harahap, Y., Setyowati, E. P., Park, M. N., Yusoff, S. D., Zainalabidin, S., Prananda, A. T., Mahadi, M. K., Kim, B., Harahap, U., & Syahputra, R. A.
Affiliations
  • Universitas Sumatera Utara (ID)
  • University of Indonesia (ID)
  • Universitas Gadjah Mada (ID)
  • Kyung Hee University (KR)
  • National University of Malaysia (MY)
Corresponding author
Syahputra, Rony Abdi
Venue
Frontiers in Pharmacology
Published
2024-11-13
Volume
15
Pages
1461478-1461478
ISSN
1663-9812 (ISSN-L)
OpenAlex
W4404340059
Cited by
50
References
276
Citations by year
2026: 39 · 2025: 11
FWCI
2.04
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Pharmacology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Research Foundation (2020R1I1A2066868, 2020R1A5A2019413)
  • Kyung Hee University (KHU-20230914, 20230914)
  • Korea Health Industry Development Institute (HF20C0038, NRF-2020R1I1A2066868)
  • National Research Foundation of Korea (2020-R1A5A2019413, 2020R1I1A2066868, NRF-2020R1I1A2066868)
  • Universitas Sumatera Utara
  • Ministry of Science and ICT, South Korea (2022-IT-RD-0205, 2022-IT-RD-0205-01-101, 2020R1A5A2019413)
  • National Institute of Environmental Health Sciences (27302C0038)
Topics
  • Physical Sciences › Chemistry › Organic Chemistry › Natural product bioactivities and synthesis
  • Physical Sciences › Chemistry › Organic Chemistry › Phytochemical Studies and Bioactivities
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Phytochemical compounds biological activities
Keywords
lupeol, pentacyclic triterpenes, lupane triterpenoids, pharmacological properties, anti-inflammatory activity, antioxidant activity, anticancer activity, antibacterial activity, bioavailability enhancement, nanoparticle drug delivery, lupeol derivatives, squalene, mevalonate pathway, medicinal plants

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.